Europe invents the future. Now let’s scale it.

European companies like ASML, Novo Nordisk, and Mistral have achieved global leadership in technology and pharmaceuticals despite structural challenges such as limited venture capital and lower capital investment. The article highlights recent growth in European venture capital and private equity, emphasizing the need to scale these successes through public-private partnerships and a unified single market.